BGI Genomics Co., Ltd. (300676.SZ)
CNY 48.27
(1.3%)
CNY 48.27
(1.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 283.42 Million CNY | 107.37% |
| 2022 | 136.68 Million CNY | -80.92% |
| 2021 | 716.4 Million CNY | 8.88% |
| 2020 | 658 Million CNY | 118.32% |
| 2019 | 301.38 Million CNY | 30138718700.0% |
| 2018 | 1.00 CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 1.00 CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 1.92 Million CNY | 0.0% |
| 2013 | - CNY | 100.0% |
| 2012 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 306.18 Million CNY | 26.48% |
| 2024 Q1 | 242.07 Million CNY | 12.24% |
| 2024 Q3 | 347.54 Million CNY | 13.51% |
| 2023 Q2 | 247.13 Million CNY | 104.06% |
| 2023 Q4 | 283.42 Million CNY | -3.15% |
| 2023 FY | 283.42 Million CNY | 107.37% |
| 2023 Q1 | 121.1 Million CNY | -11.39% |
| 2023 Q3 | 292.65 Million CNY | 18.42% |
| 2022 Q4 | 136.68 Million CNY | 38.04% |
| 2022 Q3 | 99.01 Million CNY | 29.37% |
| 2022 Q2 | 76.53 Million CNY | 5.23% |
| 2022 FY | 136.68 Million CNY | -80.92% |
| 2022 Q1 | 72.73 Million CNY | -89.85% |
| 2021 Q1 | 743.71 Million CNY | 13.03% |
| 2021 Q4 | 716.4 Million CNY | -3.78% |
| 2021 Q3 | 744.5 Million CNY | -2.25% |
| 2021 FY | 716.4 Million CNY | 8.88% |
| 2021 Q2 | 761.68 Million CNY | 2.42% |
| 2020 Q4 | 658 Million CNY | -5.64% |
| 2020 FY | 658 Million CNY | 118.32% |
| 2020 Q1 | 127.4 Million CNY | -57.73% |
| 2020 Q2 | 697.81 Million CNY | 447.74% |
| 2020 Q3 | 697.29 Million CNY | -0.07% |
| 2019 Q4 | 301.38 Million CNY | 2022575181083443000.0% |
| 2019 FY | 301.38 Million CNY | 30138718700.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | -100.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q4 | 1.00 CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q2 | - CNY | -100.0% |
| 2018 FY | 1.00 CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | 1.00 CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 FY | 1.92 Million CNY | 0.0% |
| 2013 FY | - CNY | 100.0% |
| 2012 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 2.33 Billion CNY | 87.837% |
| Hangzhou Tigermed Consulting Co., Ltd. | 434.22 Million CNY | 34.728% |
| Dirui Industrial Co.,Ltd. | 3.66 Million CNY | -7629.109% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 74.955% |
| Medicalsystem Biotechnology Co., Ltd. | 23.59 Million CNY | -1101.166% |
| Maccura Biotechnology Co.Ltd | 175.47 Million CNY | -61.517% |
| Guangzhou Wondfo Biotech Co.,Ltd | 580.52 Million CNY | 51.178% |
| Guangdong Hybribio Biotech Co.,Ltd. | 28.26 Million CNY | -902.625% |
| Amoy Diagnostics Co., Ltd. | 44.4 Million CNY | -538.349% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 166.83 Million CNY | -69.883% |